Arbor Rapha Capital Bioholdings I (Arbor Rapha Capital Bioholdings I) Interest Expense : $0.00 Mil (TTM As of Sep. 2022)

View and export this data going back to 2021. Start your Free Trial

What is Arbor Rapha Capital Bioholdings I Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Arbor Rapha Capital Bioholdings I's interest expense for the three months ended in Sep. 2022 was $ 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2022 was $0.00 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Arbor Rapha Capital Bioholdings I's Operating Income for the three months ended in Sep. 2022 was $ -0.29 Mil. Arbor Rapha Capital Bioholdings I's Interest Expense for the three months ended in Sep. 2022 was $ 0.00 Mil. GuruFocus does not calculate Arbor Rapha Capital Bioholdings I's interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Arbor Rapha Capital Bioholdings I Interest Expense Historical Data

The historical data trend for Arbor Rapha Capital Bioholdings I's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arbor Rapha Capital Bioholdings I Interest Expense Chart

Arbor Rapha Capital Bioholdings I Annual Data

Trend

Dec21

Interest Expense

Arbor Rapha Capital Bioholdings I Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Interest Expense	Get a 7-Day Free Trial			-	-	-	-	-

Arbor Rapha Capital Bioholdings I Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Arbor Rapha Capital Bioholdings I (NAS:ARCK) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Arbor Rapha Capital Bioholdings I's Interest Expense for the three months ended in Sep. 2022 was $0.00 Mil. Its Operating Income for the three months ended in Sep. 2022 was $-0.29 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2022 was $4.31 Mil.

Arbor Rapha Capital Bioholdings I's Interest Coverage for the quarter that ended in Sep. 2022 is calculated as

GuruFocus does not calculate Arbor Rapha Capital Bioholdings I's interest coverage with the available data.

The higher the ratio, the stronger the company's financial strength is.

Arbor Rapha Capital Bioholdings I (Arbor Rapha Capital Bioholdings I) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Arbor Rapha Capital Bioholdings Corp I (NAS:ARCK) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

333 Earle Ovington Boulevard, Suite 900, Uniondale, NY, USA, 11553

Website

https://arcbiocorp.com

Arbor Rapha Capital Bioholdings Corp I is a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

Executives

Ralph Mack	director	333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553
Kevin M. Slawin	director, officer: Chief Strategy Officer	C/O BELLICUM PHARMACEUTICALS, INC., 2130 W. HOLCOMBE BLVD., STE. 800, HOUSTON TX 77030
Ivan Kaufman	director, 10 percent owner, officer: Chief Executive Officer
Arbor Commercial Mortgage Llc	director, 10 percent owner, officer: Chief Executive Officer	333 EARLE OVINGTON BLVD, STE 900, UNIONDALE NY 11553
Paul Elenio	officer: Chief Financial Officer	C/O ARBOR REALTY TRUST, 333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553
John Natalone	officer: Treasurer	C/O ARBOR REALTY TRUST, INC., 333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553
William P Connolly	officer: Secretary & Vice President	C/O ARBOR REALTY TRUST INC., 333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553
Cyrus D. Walker	director	C/O MARIPOSA CAPITAL, LLC, 500 SOUTH POINTE DRIVE, SUITE 240, MIAMI BEACH FL 33139
Arbor Rapha Capital Llc	director, 10 percent owner, officer: Chief Executive Officer	333 EARLE OVINGTON BLVD., SUITE 900, UNIONDALE NY 11553
Avery Modlin	director	C/O ARBOR REALTY TRUST INC., 333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553

Arbor Rapha Capital Bioholdings I (Arbor Rapha Capital Bioholdings I) Headlines

From GuruFocus

Arbor Rapha Capital Bioholdings Corp. I Announces Closing of $172.5 Million Initial Public Offering

By PRNewswire PRNewswire • 11-02-2021

Arbor Rapha Capital Bioholdings Corp. I Announces the Separate Trading of its Shares of Class A Common Stock and Redeemable Warrants Commencing December 20, 2021

By PRNewswire PRNewswire • 12-17-2021